|1.||Seçkin, Berna: 1 article (07/2014)|
|2.||Özyer, Sebnem: 1 article (07/2014)|
|3.||Uzunlar, Özlem: 1 article (07/2014)|
|4.||Özcan, Nagihan: 1 article (07/2014)|
|5.||Sargın Oruç, Ayla: 1 article (07/2014)|
|6.||Danışman, Nuri: 1 article (07/2014)|
|7.||Goh, Fernie: 1 article (10/2010)|
|8.||Simpson, Nicholas E: 1 article (10/2010)|
|9.||Sambanis, Athanassios: 1 article (10/2010)|
|10.||Gross, Jeffrey D: 1 article (10/2010)|
02/01/1997 - "Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against reperfusion injury in ischemic rabbit lungs."
01/01/1994 - "To evaluate the efficacy of a perflurocarbon emulsion (Fluosol: FC-43) for protecting preserved lungs from ischemic reperfusion injuries, we employed an isolated canine left lung reperfusion model. "
|2.||Liver Diseases (Liver Disease)
10/01/1989 - "This test improved the detection rate of FTBA for the liver dysfunction and reflects the severity of the diseases. "
01/01/1994 - "Comparison between FTBA, PTBA and other liver function tests in various liver diseases from this study the PTBA was not statistically significant superior to FTBA. "
12/01/1996 - "Langendorff hearts perfused at 37 degrees C with the perfluorochemical emulsion Fluosol-43 were subjected to 15 min and 30 min of zero-flow ischemia and to 15 min of low-flow ischemia (coronary perfusion pressure = 20 mmHg) followed by 65 min of reperfusion (control, Group I). "
01/01/1995 - "When examined 1 day after a 90-minute interval of ischemia, oxygenated FTBA-filled eyes maintained 45% and 57% of the preischemic ERG a- and b-wave amplitudes, respectively, compared to a 5% and 3% retention of wave amplitudes in oxygenated BSS-filled eyes. "
01/01/1985 - "This study reports an assessment of a method of intestinal protection by the intraluminal administration of an oxygenated perfluorochemical, perfluorotributylamine, or gaseous oxygen in an attempt to provide oxygen for mucosal cells rendered ischemia. "
01/01/1995 - "Over a 10- or 30-minute period of ischemia, during which electroretinographic (ERG) responses were recorded, FTBA-filled eyes and BSS-filled eyes showed decreases in the a- and b-wave amplitudes. "
08/01/1997 - "The effect of thromboxane A2 synthetase inhibitor (OKY-046) on myocardial metabolism and contractility during ischemia and reperfusion was examined by the phosphorus 31-nuclear magnetic resonance (31P-NMR) in Langendorff rabbit hearts with use of an artificial blood substitute, perfluorochemical emulsion Fluosol-43. "
06/01/1982 - "The tumor-bearing rats for 10 days after implantation were randomly divided into 4 groups; a control group, a Fluosol-43 treatment group, a BCNU treatment group, and a Fluosol-43 plus BCNU treatment group. "
08/01/1993 - "An emulsion of perfluorotributylamine (FTBA) was used as a vascular contrast agent for 19F MRI: The amount of emulsion in the tumor vasculature was measured by 19F MRI and used to calculate percent vascular volume. "
09/01/1989 - "Multiresonance perfluorocarbon emulsions (Oxypherol and Fluosol-DA) were imaged in tumor-bearing mice using 19F spin-echo magnetic resonance imaging in vivo. "
09/01/1987 - "Anticarcino-embryonic antigen (CEA) antibody conjugated with perfluorochemical (perfluorotributylamine, FTBA) was administered to nude mouse inoculated with LOVO, a CEA-producing human cancer cell line. "
|1.||Poloxamer (Poloxamer 407)
|4.||Bile Acids and Salts (Bile Acids)
|5.||perfluorotributylamine (FC 43)
|7.||Blood Substitutes (Artificial Blood)
|1.||Drug Therapy (Chemotherapy)